Anaplastic large cell lymphoma and lepromatous leprosy: a rare coexistence.
Lepromatous leprosy (LL) has been reported in the literature with Non Hodgkin Lymphoma and rarely with Hodgkin Lymphoma. However, an extensive search of the literature shows no case report describing anaplastic large cell lymphoma (ALCL) in association with LL. We report a case of a young male with LL who was found to have ALCL. This is an interesting case of coexistence of an endemic infectious disease and a rare lymphoma involving the same lymph node, with a brief review of the literature.
Maulana Azad Medical College, New Delhi- 110002, India.
Nidhi
N
Mahajan
Seema
S
Rao
Parul
P
Sobti
Nita
N
Khurana
Vijay Kumar
VK
Garg
Shyama
S
Jain
D000328:Adult; D053144:Cell Nucleus Shape; D002991:Clofazimine / Q000008:administration & dosage / Q000627:therapeutic use; D006644:Histiocytes / Q000737:chemistry / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D017730:Ki-1 Antigen / Q000737:chemistry; D015440:Leprosy, Lepromatous / Q000150:complications* / Q000188:drug therapy; D008198:Lymph Nodes / Q000473:pathology*; D017728:Lymphoma, Large-Cell, Anaplastic / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D008297:Male; D009166:Mycobacterium leprae / Q000302:isolation & purification / Q000472:pathogenicity; D010198:Pancytopenia / Q000188:drug therapy / Q000473:pathology; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D017192:Skin Diseases, Bacterial / Q000382:microbiology / Q000473:pathology
D017730:Ki-1 Antigen; D002991:Clofazimine; D012293:Rifampin